Cosentyx — Medical Mutual

Initial criteria

• Patient age ≥ 6 years
• Patient has tried at least one traditional systemic agent for ≥ 3 months unless intolerant OR has tried at least one biologic other than Cosentyx OR patient has contraindication to methotrexate
• Prescribed by or in consultation with a dermatologist

Reauthorization criteria

• Patient has been established on therapy for at least 90 days
• Patient experienced beneficial clinical response from baseline in estimated body surface area, erythema, induration/thickness, or scale of areas affected
• Patient experienced improvement in at least one symptom such as decreased pain, itching, or burning

Approval duration

initial 3 months; reauth 1 year